Gritstone Bio Inc (GRTS) Return on Equity ROE from the second quarter 2024 to second quarter 2023 and annually, average high and low, overall ranking from Jun 30 2024 to Jun 30 2023 - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Gritstone Bio Inc   (NASDAQ: GRTS)

Gritstone Bio Inc 's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics


What is ROE for Gritstone Bio Inc in the second quarter 2024?
Gritstone Bio Inc recorded a cumulative net loss of $-201 million during 12 months ending in the second quarter 2024, resulting in a negative return on equity (ROE) of -496.33%.

Within the Biotechnology & Pharmaceuticals industry 121 other companies had a higher return on equity. While return on equity, the total ranking has deteriorated compared to the first quarter 2024 from 0 to 3776.

What is ROE?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Equity (Jun 30 2024)
II. Quarter		 (Mar 31 2024)
I. Quarter		 (Dec 31 2023)
IV. Quarter		 (Sep 30 2023)
III. Quarter		 (Jun 30 2023)
II. Quarter
Y / Y Equity Change -79.75 % -90.09 % -69.64 % -45.94 % -
Y / Y Net Income Change - - - - -
Net Income (TTM) in Millions -201 -213 -138 -71 -63
Return On Equity (TTM) -496.33 % -341.44 % -147.22 % -57.35 % -44.82 %
GRTS's Total Ranking # 3776 # 0 # 0 # 3222 # 2562
Equity (TTM) in Millions 22 14 52 74 110
Seq. Equity Change 58.9 % -73.07 % -29.92 % -32.48 % -22.23 %
Seq. Net Income Change - - - - -

Back to GRTS Management Effectiveness >> GRTS's 5 Years Annual ROE >> Compare GRTS ROE to its Competitors
Return On Equity Company Ranking
Within: No.
Industry # 122
Sector # 771
Overall # 3776

Return On Equity Statistics
High Average Low
-29.22 %
-96.57 %
-496.33 %
(Jun 30 2019)   (Jun 30 2024)





GRTS Annual Return On Equity (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021		 (Dec 31 2020)
2020		 (Dec 31 2019)
2019
Total Equity in Millions 52 171 216 167 134
Y / Y Equity Change -69.64 % -20.97 % 29.6 % 24.11 % -9.91 %
Net Income in Millions -138 -120 -75 -105 -94
Y / Y Net Income Change - - - - -
Return On Equity -267.1 % -70.08 % -34.75 % -63.16 % -70.29 %

Back to GRTS Management Effectiveness >> GRTS's 5 Years Annual ROE >> Compare GRTS ROE to its Competitors




More Return On Equity Ratios
Biotechnology & Pharmaceuticals Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
GRTS's' Return on Equity at Yahoo Finance
GRTS's Roe Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for GRTS's Competitors
Subscribers only: Roe for Gritstone Bio Inc 's Suppliers
Subscribers only: Return On Equity for GRTS's Customers




Companies with similar Return On Equity at Jun 30 2024, within Healthcare Sector ROE

Date modified: 2026-09-18T13:11:05+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.